These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Boolean model of anchorage dependence and contact inhibition points to coordinated inhibition but semi-independent induction of proliferation and migration. Guberman E; Sherief H; Regan ER Comput Struct Biotechnol J; 2020; 18():2145-2165. PubMed ID: 32913583 [TBL] [Abstract][Full Text] [Related]
4. Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response. Jia D; Li X; Bocci F; Tripathi S; Deng Y; Jolly MK; Onuchic JN; Levine H J Clin Med; 2019 May; 8(5):. PubMed ID: 31121840 [TBL] [Abstract][Full Text] [Related]
5. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression. Sinha D; Saha P; Samanta A; Bishayee A Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810 [TBL] [Abstract][Full Text] [Related]
6. Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypes. Steinway SN; Zañudo JGT; Michel PJ; Feith DJ; Loughran TP; Albert R NPJ Syst Biol Appl; 2015; 1():15014. PubMed ID: 28725463 [TBL] [Abstract][Full Text] [Related]
7. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT). Subbalakshmi AR; Sahoo S; Biswas K; Jolly MK Cells Tissues Organs; 2022; 211(6):689-702. PubMed ID: 33567424 [TBL] [Abstract][Full Text] [Related]
8. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling. Bocci F; Jolly MK; George JT; Levine H; Onuchic JN Oncotarget; 2018 Jul; 9(52):29906-29920. PubMed ID: 30042822 [TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition. Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG; Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020 [TBL] [Abstract][Full Text] [Related]
10. Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling. Bocci F; Jolly MK; Tripathi SC; Aguilar M; Hanash SM; Levine H; Onuchic JN J R Soc Interface; 2017 Nov; 14(136):. PubMed ID: 29187638 [TBL] [Abstract][Full Text] [Related]
11. TGFβ selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial-mesenchymal transition. Tsubakihara Y; Ohata Y; Okita Y; Younis S; Eriksson J; Sellin ME; Ren J; Ten Dijke P; Miyazono K; Hikita A; Imamura T; Kato M; Heldin CH; Moustakas A Mol Oncol; 2022 Jun; 16(12):2330-2354. PubMed ID: 35348275 [TBL] [Abstract][Full Text] [Related]
12. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype. Subbalakshmi AR; Kundnani D; Biswas K; Ghosh A; Hanash SM; Tripathi SC; Jolly MK Front Oncol; 2020; 10():553342. PubMed ID: 33014880 [TBL] [Abstract][Full Text] [Related]
13. A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States. Kim N; Hwang CY; Kim T; Kim H; Cho KH Cancer Res; 2023 Mar; 83(6):956-970. PubMed ID: 36710400 [TBL] [Abstract][Full Text] [Related]
14. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ. Tan EJ; Olsson AK; Moustakas A Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613 [TBL] [Abstract][Full Text] [Related]
15. Stability of the hybrid epithelial/mesenchymal phenotype. Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704 [TBL] [Abstract][Full Text] [Related]
16. Coupling the modules of EMT and stemness: A tunable 'stemness window' model. Jolly MK; Jia D; Boareto M; Mani SA; Pienta KJ; Ben-Jacob E; Levine H Oncotarget; 2015 Sep; 6(28):25161-74. PubMed ID: 26317796 [TBL] [Abstract][Full Text] [Related]
17. Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis. Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Joven J; Menendez JA Cell Cycle; 2010 Nov; 9(22):4461-8. PubMed ID: 21088486 [TBL] [Abstract][Full Text] [Related]
18. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Jolly MK; Boareto M; Huang B; Jia D; Lu M; Ben-Jacob E; Onuchic JN; Levine H Front Oncol; 2015; 5():155. PubMed ID: 26258068 [TBL] [Abstract][Full Text] [Related]
19. Deciphering Epithelial-Mesenchymal Transition Regulatory Networks in Cancer through Computational Approaches. Burger GA; Danen EHJ; Beltman JB Front Oncol; 2017; 7():162. PubMed ID: 28824874 [TBL] [Abstract][Full Text] [Related]
20. A role for partial epithelial-to-mesenchymal transition in enabling stemness in homeostasis and cancer. Verstappe J; Berx G Semin Cancer Biol; 2023 May; 90():15-28. PubMed ID: 36773819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]